Post-cardiac arrest care system improved survivors' neurologic status

July 30, 2012

Fewer sudden cardiac arrest survivors had neurologic impairment after a novel regional system of care was implemented, according to research published in Circulation, an American Heart Association journal.

In 2009, the Aizu region of Japan established an advanced post-cardiac arrest care system that included (EMS) taking survivors directly to hospitals specializing in advanced care or from an outlying hospital to the specialty hospital after an effective heartbeat was restored.

Advanced care includes therapeutic hypothermia, appropriate fluids, cardiovascular medications, respiratory management and procedures like percutaneous (PCI) to open blocked arteries.

The American Heart Association refers to these treatments as the "fifth link" in the Chain of Survival for sudden cardiac arrest.

Comparing data on patients who had suffered cardiac arrest before and after the regional system was implemented, researchers found:

  • Survival to improved significantly, from 2.3 percent before to 4.2 percent after.
  • After a month, 51 percent of surviving patients had favorable neurologic outcomes after vs. 19 percent before.
  • Seventy-six percent of those whose heartbeat was restored received therapeutic hypothermia after vs. 11 percent before.
  • All patients received appropriate hemodynamic management by using advanced hemodynamic after vs. 0 percent before.
"Although there were concerns that the proportion of survivors with severe neurologic disability would increase, this did not occur," said Takashi Tagami, M.D., Ph.D., lead author of the study and an assistant professor at Nippon Medical School in Tokyo, Japan. "These findings suggest that the 'fifth link' is associated with an increase in survival rate as well as improvement of quality of life among survivors."

One-month survival with a favorable neurologic outcome among all patients treated by EMS providers improved significantly after implementation of the fifth link – from 0.5 percent to 3 percent. Participants included 1,482 cardiac arrest patients in the Aizu region (Fukushima, Japan). Fifty-eight percent were male and the average age was 76. The pre-intervention period was January 2006 to April 2008 and post-intervention was January 2009 to December 2010.

Each year in the United States, more than 380,000 people suffer outside the hospital. The survival rate for non-traumatic cardiac arrest is extremely low 󈝷.4 percent for those treated by EMS. Immediate, rapid and seamless care is essential to recovery.

In 2000, the recommended the "Chain of Survival" for cardiac arrest treatment. The four links in the "chain" included calling 9-1-1 for early access to emergency medical care; early CPR; early defibrillation; and early advanced cardiovascular life support. The association added the "fifth link" in its 2010 resuscitation guidelines.

"Post- care requires a multidisciplinary approach to intensive care that is difficult to implement in a non-specialized hospital," Tagami said. "This study indicates that the introduction of the regional resuscitation system of care, the 'fifth link,' made it possible to treat all potential survivors in the ICU of a specialized hospital."

Explore further: 9-1-1 dispatchers can save more lives by coaching bystanders in CPR

Related Stories

9-1-1 dispatchers can save more lives by coaching bystanders in CPR

January 9, 2012
More people will survive sudden cardiac arrest when 9-1-1 dispatchers help bystanders assess victims and begin CPR immediately, according to a new American Heart Association scientific statement published in Circulation: ...

Regional system to cool cardiac arrest patients improves outcomes

July 11, 2011
A broad, regional system to lower the temperature of resuscitated cardiac arrest patients at a centrally-located hospital improved outcomes, according to a study in Circulation: Journal of the American Heart Association.

200,000 patients treated for cardiac arrest annually in US hospitals, study shows

June 24, 2011
More than 200,000 people are treated for cardiac arrest in United States hospitals each year, a rate that may be on the rise. The findings are reported online this week in Critical Care Medicine in a University of Pennsylvania ...

Black cardiac arrest patients more likely to be admitted to hospitals with lowest survival rates

April 29, 2011
Black cardiac arrest victims are more likely to die when they're treated in hospitals that care for a large black population than when they're brought to hospitals with a greater proportion of white patients, according to ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.